HALISTER: Bayer’s $14.2 Billion Merck Buy Exposes Split in Pharma Strategy

Bayer’s $14.2 Billion Merck Buy Exposes Split in Pharma Strategy

Alert: HALISTER Source: BN (Bloomberg News)

Tickers MRK US (Merck & Co Inc) BAYN GR (Bayer AG)

People Christopher Viehbacher (Sanofi) Hans Bishop (Juno Therapeutics Inc) Helena Strettle (Sanford C Bernstein Ltd) Marijn Dekkers (Bayer AG)

Topics Cancers

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283